- Report
- February 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- September 2026
- 182 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- June 2026
- 110 Pages
Global
From €4387EUR$4,750USD£3,670GBP
- Report
- March 2026
Europe
From €3187EUR$3,450USD£2,665GBP
- Report
- March 2026
Asia Pacific
From €3187EUR$3,450USD£2,665GBP
- Report
- March 2026
Africa, Middle East
From €3187EUR$3,450USD£2,665GBP
- Report
- March 2026
North America
From €3187EUR$3,450USD£2,665GBP
- Report
- March 2026
- 147 Pages
Global
From €3694EUR$3,999USD£3,089GBP
- Report
- June 2026
- 601 Pages
Global
From €4110EUR$4,450USD£3,438GBP
- Report
- April 2026
- 924 Pages
Global
From €4110EUR$4,450USD£3,438GBP
- Report
- June 2026
- 200 Pages
Europe
From €2762EUR$2,990USD£2,310GBP
- Report
- June 2023
- 142 Pages
Global
From €4618EUR$5,000USD£3,863GBP
- Report
- January 2023
- 178 Pages
Global
From €4618EUR$5,000USD£3,863GBP
- Report
- April 2022
- 264 Pages
Global
From €5542EUR$6,000USD£4,635GBP
- Report
- April 2024
- 261 Pages
Global
From €2263EUR$2,450USD£1,893GBP
- Report
- May 2025
- 354 Pages
Global
From €4433EUR$4,799USD£3,708GBP
- Report
- January 2025
- 159 Pages
Global
From €4295EUR$4,650USD£3,592GBP
- Report
- August 2024
- 242 Pages
Africa
From €3856EUR$4,175USD£3,225GBP
- Report
- May 2025
- 200 Pages
Italy
From €2300EUR$2,490USD£1,924GBP
- Report
- May 2025
- 200 Pages
Europe
From €2300EUR$2,490USD£1,924GBP

The In Vitro Diagnostics (IVD) Infectious Disease market is a segment of the larger IVD industry that focuses on the diagnosis and monitoring of infectious diseases. It includes a range of products and services, such as tests for the detection of bacteria, viruses, fungi, and parasites, as well as tests for the identification of drug-resistant organisms. These tests are used to diagnose and monitor the progression of infectious diseases, as well as to guide treatment decisions.
The IVD Infectious Disease market is driven by the increasing prevalence of infectious diseases, the emergence of new and drug-resistant pathogens, and the need for rapid and accurate diagnosis. Additionally, technological advances in molecular diagnostics, such as PCR and next-generation sequencing, have enabled the development of more sensitive and specific tests.
Notable companies in the IVD Infectious Disease market include Abbott, Becton Dickinson, Roche, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more